Advertisement

Index by author

January 01, 2024; Volume 388,Issue 1

  1. Onay-besikci, Arzu

    1. Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction
      Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction
      Berna Güven, Qiuyu Sun, Cory S. Wagg, Amanda Almeida de Oliveira, Heidi Silver, Kaya L. Persad, Arzu Onay-Besikci, Jennie Vu, Gavin Y. Oudit and Gary D. Lopaschuk
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 145-155; DOI: https://doi.org/10.1124/jpet.123.001791

  2. Otsuki, Kaita

    1. Time-Dependent Differences in Vancomycin Sensitivity of Macrophages Underlie Vancomycin-Induced Acute Kidney Injury
      Yuya Yoshida, Taiki Fukuda, Kohei Fukuoka, Toshitaka Nagayama, Tomohito Tanihara, Naoki Nishikawa, Kaita Otsuki, Yuma Terada, Kengo Hamamura, Kosuke Oyama, Akito Tsuruta, Kota Mayanagi, Satoru Koyanagi, Naoya Matsunaga and Shigehiro Ohdo
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 218-227; DOI: https://doi.org/10.1124/jpet.123.001864

  3. Oudit, Gavin Y.

    1. Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction
      Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction
      Berna Güven, Qiuyu Sun, Cory S. Wagg, Amanda Almeida de Oliveira, Heidi Silver, Kaya L. Persad, Arzu Onay-Besikci, Jennie Vu, Gavin Y. Oudit and Gary D. Lopaschuk
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 145-155; DOI: https://doi.org/10.1124/jpet.123.001791

  4. Oyama, Kosuke

    1. Time-Dependent Differences in Vancomycin Sensitivity of Macrophages Underlie Vancomycin-Induced Acute Kidney Injury
      Yuya Yoshida, Taiki Fukuda, Kohei Fukuoka, Toshitaka Nagayama, Tomohito Tanihara, Naoki Nishikawa, Kaita Otsuki, Yuma Terada, Kengo Hamamura, Kosuke Oyama, Akito Tsuruta, Kota Mayanagi, Satoru Koyanagi, Naoya Matsunaga and Shigehiro Ohdo
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 218-227; DOI: https://doi.org/10.1124/jpet.123.001864

  5. Park, Jae B.

    1. Methyl 2-[3-(4-hydroxyphenyl)prop-2-enoylamino]-3-phenylpropanoate Is a Potent Cell-Permeable Anti-Cytokine Compound To Inhibit Inflammatory Cytokines in Monocyte/Macrophage-Like Cells
      Jae B. Park
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 181-189; DOI: https://doi.org/10.1124/jpet.123.001830

  6. Patel, Bhaumik

    1. High-Dose Acetaminophen with Concurrent CYP2E1 Inhibition Has Profound Anticancer Activity without Liver Toxicity
      Allyn Bryan, Pavani Pingali, Anthony Faber, Joseph Landry, Jephte Y. Akakpo, Hartmut Jaeschke, Howard Li, Won Sok Lee, Lauren May, Bhaumik Patel and Alex Neuwelt
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 209-217; DOI: https://doi.org/10.1124/jpet.123.001772

  7. Persad, Kaya L.

    1. Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction
      Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction
      Berna Güven, Qiuyu Sun, Cory S. Wagg, Amanda Almeida de Oliveira, Heidi Silver, Kaya L. Persad, Arzu Onay-Besikci, Jennie Vu, Gavin Y. Oudit and Gary D. Lopaschuk
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 145-155; DOI: https://doi.org/10.1124/jpet.123.001791

  8. Pingali, Pavani

    1. High-Dose Acetaminophen with Concurrent CYP2E1 Inhibition Has Profound Anticancer Activity without Liver Toxicity
      Allyn Bryan, Pavani Pingali, Anthony Faber, Joseph Landry, Jephte Y. Akakpo, Hartmut Jaeschke, Howard Li, Won Sok Lee, Lauren May, Bhaumik Patel and Alex Neuwelt
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 209-217; DOI: https://doi.org/10.1124/jpet.123.001772

  9. Poluri, Krishna Mohan

    1. Protein-Based Nanocarriers and Nanotherapeutics for Infection and Inflammation
      Protein-Based Nanocarriers and Nanotherapeutics for Infection and Inflammation
      Nupur Nagar, Goutami Naidu, Amit Mishra and Krishna Mohan Poluri
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 91-109; DOI: https://doi.org/10.1124/jpet.123.001673

  10. Pye, Keith

    1. Significance of Organic Anion Transporter 2 and Organic Cation Transporter 2 in Creatinine Clearance: Mechanistic Evaluation Using Freshly Prepared Human Primary Renal Proximal Tubule Cells
      Sumathy Mathialagan, Git Chung, Keith Pye, A. David Rodrigues, Manthena V. S. Varma and Colin Brown
      Journal of Pharmacology and Experimental Therapeutics January 2024, 388 (1) 201-208; DOI: https://doi.org/10.1124/jpet.123.001890
« Previous (Pages : 5 6 7 8 9 10 11 12 13 14 ... 14) Next »
Back to top

In this issue

Advertisement